XML 22 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Statement of Cash Flows
$ in Thousands
12 Months Ended
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ 63,859 $ 114,932 $ 258,626
Adjustments to reconcile income to net cash provided by operating activities:      
Share-based Compensation 22,079 21,279 20,470
Depreciation and amortization 26,872 27,457 26,696
Debt issuance costs amortization and finance charges 501 702 445
(Increase) decrease in value of life insurance policies (824) 909 (1,581)
Increase (Decrease) in Deferred Income Taxes (14,385) (107) 4,682
Asset Impairment Charges 0 5,199 0
Provision for Doubtful Accounts (18) 2,592 1,243
Other Noncash Income (Expense) (1,399) (860) (466)
Changes in assets and liabilities, net of effects of acquisitions:      
Accounts receivable 31,584 49,261 3,486
Inventories 6,219 3,049 2,894
Prepaid expenses and other current assets 2,657 7,744 (10,088)
Increase (Decrease) in Deferred Revenue 1,589 3,092 121
Other assets 340 2,652 680
Accounts payable (1,036) (13,353) (3,021)
Accrued expenses (6,738) (9,723) (2,611)
Other long-term liabilities 587 4,275 1,873
Net cash provided by operating activities 131,887 219,100 303,449
CASH FLOWS FROM INVESTING ACTIVITIES:      
Capital expenditures (11,356) (22,797) (36,586)
Patents and other intangibles (348) (1,460) (854)
Acquisitions, net of cash acquired (1,242) (13,774) (1,200)
Proceeds from sale of assets 740 1,320 884
Premiums on life insurance (2,515) (2,943) (4,310)
Net cash used in investing activities (14,721) (39,654) (42,066)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Repayment of debt borrowings (316,244) (139,656) (128,162)
Proceeds from debt borrowings 99,000 215,000 217,000
Excess tax benefits from stock-based payments (1,162) (175) 3,020
Debt financing costs 0 (387) (1,128)
Non-controlling interest - dividend (1,386) (1,140) (394)
Dividends paid (95,145) (94,235) (89,089)
Repurchase of common shares (7,161) (159,709) (264,368)
Proceeds from Issuance of Common Stock 197,202 0 0
Net cash used in financing activities (124,896) (180,302) (263,121)
NET CHANGE IN CASH AND CASH EQUIVALENTS (7,730) (856) (1,738)
Cash and Cash Equivalents, at Carrying Value 14,764 22,494 23,350
Cash payments for interest 11,248 12,313 10,272
Cash payments for income taxes 12,181 35,523 79,644
Non-cash investing and financing activities:      
Financed capital expenditures 1,627 483 1,009
Insurance premium financed $ 0 $ 2,228 $ 0